The AFM-Téléthon, the University Hospitals of Strasbourg, and the Center Hospitalier Universitaire de Bordeaux are launching a pilot project called DEPISMA for neonatal genetic screening for spinal muscular atrophy (SMA) in the Grand-Est and in Nouvelle-Aquitaine regions of France, in collaboration with the regional health agencies. The first babies to be screened for SMA will be in September 2022.
We are proud to announce that SMA Europe has officially joined the Screen4Rare platform as a Partner!
The European Alliance for SMA Newborn Screening is proud to share some developments in Serbia and Latvia for SMA newborn screening.
Read the new publication from a group of Scottish experts on the need for SMA newborn screening.